Can Liver Disease Cause Bone Loss or Osteoporosis?

Yes — and it's one of the most underdiagnosed complications of chronic liver disease. The connection between your liver and your bones isn't obvious — most patients and even some doctors don't think to link the two. But the medical reality is clear: up to 40% of patients with cirrhosis have some degree of bone disease, and the risk of fractures in this population is significantly higher than in the general public.

The umbrella term is hepatic osteodystrophy — bone disease caused by liver disease. It encompasses both osteoporosis (loss of bone density) and osteomalacia (defective bone mineralization from vitamin D deficiency). For patients already dealing with ascites, encephalopathy, bleeding risk, and dietary restrictions, the idea that their bones are also deteriorating silently adds yet another layer of complexity to an already overwhelming disease. But knowing about it means you can screen for it, prevent it, and treat it — before a fracture happens.

Why your liver affects your bones

Bone is living tissue that's constantly being remodeled — old bone is broken down (resorption) and new bone is built (formation) in a carefully balanced cycle. When that balance tips toward resorption exceeding formation, bone density declines and osteoporosis develops. Liver disease disrupts this balance through multiple mechanisms simultaneously:

Vitamin D deficiency

This is the most important and most treatable mechanism. Your liver performs a critical step in activating vitamin D: it converts the inactive form (cholecalciferol, from sunlight or supplements) into 25-hydroxyvitamin D (calcidiol) — the form that's measured on blood tests. In liver disease, this conversion is impaired, leading to vitamin D deficiency even in patients with adequate sun exposure or supplementation.

Vitamin D is essential for calcium absorption from your gut. Without adequate vitamin D, you can't absorb enough calcium regardless of how much you consume — and without calcium, your body pulls it from the only reservoir available: your bones. The result is progressive bone demineralization.

In cholestatic liver diseases (primary biliary cholangitis, primary sclerosing cholangitis), the problem is compounded because bile flow is impaired, and bile is needed to absorb fat-soluble vitamins — including vitamin D. This is why bone disease is most severe in cholestatic conditions.

Hypogonadism (low sex hormones)

Cirrhosis frequently causes hypogonadism — low testosterone in men and low estrogen in postmenopausal women (who lose the protective ovarian estrogen production). Both testosterone and estrogen are critical for maintaining bone density. Testosterone stimulates osteoblast (bone-building) activity. Estrogen inhibits osteoclast (bone-destroying) activity. When both are deficient — as is common in advanced cirrhosis — bone loss accelerates from both directions.

In men with cirrhosis, testosterone deficiency affects 50–90% of patients and contributes to bone loss, muscle wasting, fatigue, and sexual dysfunction simultaneously. It's one of the most impactful hormonal disruptions in liver disease, and it's often untreated because it's not tested for.

Chronic inflammation

The persistent inflammatory state of liver disease produces cytokines (TNF-alpha, IL-1, IL-6) that directly stimulate osteoclasts — the cells that break down bone. This is the same mechanism that causes bone loss in other chronic inflammatory diseases (rheumatoid arthritis, inflammatory bowel disease). Your immune system, constantly activated by liver inflammation, is inadvertently attacking your skeleton.

Malnutrition and sarcopenia

Malnutrition in cirrhosis isn't just about calories and protein — it affects micronutrients critical for bone health. Calcium, phosphorus, magnesium, vitamin K, and zinc are all frequently deficient. Additionally, sarcopenia (muscle wasting) reduces the mechanical load on bones, which further accelerates bone loss — your skeleton needs the stress of muscle contraction to maintain density.

Medications

Several medications commonly used in liver disease can worsen bone health. Corticosteroids (used in autoimmune hepatitis) are potent drivers of bone loss. Proton pump inhibitors (PPIs), commonly used for reflux and variceal bleeding prevention, reduce calcium absorption with long-term use. Loop diuretics (furosemide) increase calcium excretion in urine. Cholestyramine (used for itching) can impair absorption of fat-soluble vitamins including vitamin D.

Alcohol

Alcohol is directly toxic to osteoblasts (bone-building cells) and independently promotes bone loss — separate from and additive to its liver-damaging effects. Patients with alcohol-related liver disease have the highest rates of osteoporosis among all cirrhosis causes, because they're hit by both the liver dysfunction and the direct bone toxicity of alcohol.

Who's most at risk

While all cirrhosis patients have elevated bone disease risk, certain groups are at particularly high risk:

• Cholestatic liver diseases (PBC, PSC) — highest rates of osteoporosis, up to 40–55% in some studies. The impaired bile flow severely compromises fat-soluble vitamin absorption.

• Alcohol-related liver disease — dual mechanism: liver dysfunction + direct alcohol bone toxicity.

• Postmenopausal women with cirrhosis — loss of ovarian estrogen protection compounds liver-related bone loss.

• Men with cirrhosis and hypogonadism — testosterone deficiency accelerates bone resorption.

• Patients on long-term corticosteroids — autoimmune hepatitis patients on prednisone.

• Pre- and post-transplant patients — bone loss accelerates in the first 3–6 months after transplant (from high-dose immunosuppression), before gradually improving. Patients with pre-existing osteoporosis at transplant are at highest fracture risk during recovery.

• Patients with low BMI or sarcopenia — reduced mechanical loading on bones.

• Anyone with documented vitamin D deficiency — which is nearly universal in cirrhosis.

What bone loss looks like — and why you may not know it's happening

Osteoporosis is called a "silent disease" for a reason: you feel absolutely nothing as your bones get weaker. There's no pain, no symptom, no signal — until a fracture happens. And in cirrhosis patients with impaired clotting, compromised nutrition, and reduced physical reserve, a fracture can be a catastrophic event.

The most common fracture sites in osteoporosis are vertebral compression fractures (spine — these can happen from something as minor as bending forward or coughing, causing sudden back pain, loss of height, or hunched posture), hip fractures (devastating in any population — 20–30% mortality within one year in elderly patients, and cirrhosis patients face even higher risk due to coagulopathy, malnutrition, and surgical risk), and wrist fractures (from falls — common in cirrhosis patients with muscle weakness, encephalopathy, or medication-related dizziness).

The frightening reality: many vertebral compression fractures in cirrhosis patients are not recognized because the back pain is attributed to other causes or dismissed as "aging." A patient loses height gradually — half an inch here, a quarter inch there — and nobody connects it to bone loss until imaging reveals multiple crushed vertebrae.

How to screen for bone loss

Bone density screening in liver disease patients is underutilized. The test is simple, painless, and widely available:

DEXA scan (Dual-Energy X-ray Absorptiometry) — the gold standard for measuring bone density. It takes 10–15 minutes, involves minimal radiation, and produces a T-score that tells you where your bone density stands:

Who should get a DEXA scan: All patients with cholestatic liver disease (PBC, PSC). All cirrhosis patients being evaluated for transplant. All cirrhosis patients with additional risk factors (postmenopausal women, men with hypogonadism, chronic corticosteroid use, history of fragility fracture, low BMI). Many hepatologists recommend baseline DEXA for all cirrhosis patients — especially given how easy and inexpensive the test is.

Additionally, get your vitamin D level checked (25-hydroxyvitamin D on blood work). Deficiency is nearly universal in cirrhosis — the question is how severe it is and how aggressively it needs to be repleted. Track your vitamin D levels alongside your other liver labs by uploading lab reports to LiverTracker.

How to protect your bones

Vitamin D supplementation

The AASLD 2021 Practice Guidance recommends routine vitamin D testing and repletion for all cirrhosis patients. Typical supplementation ranges from 1,000–4,000 IU/day of vitamin D3 (cholecalciferol) for maintenance, with higher loading doses (50,000 IU weekly for 8–12 weeks) for documented severe deficiency. Your hepatologist should monitor your 25-OH vitamin D level and adjust dosing accordingly. The target is generally 30–50 ng/mL.

In cholestatic conditions where oral absorption is impaired, parenteral (injected) vitamin D may be needed.

Calcium intake

Aim for 1,000–1,200 mg of calcium per day — ideally through dietary sources (dairy products, fortified plant milks, leafy greens, sardines, tofu). If dietary intake is insufficient, a calcium supplement (calcium citrate is preferred over calcium carbonate in patients on PPIs, because citrate doesn't require stomach acid for absorption) can fill the gap. Don't exceed 2,000 mg/day total from food plus supplements — excess calcium has its own risks.

Weight-bearing exercise

Exercise that puts mechanical stress on bones stimulates bone formation. Walking, stair climbing, dancing, light resistance training, and any activity where your muscles pull against your skeleton helps maintain bone density. Even in the context of cirrhosis-related fatigue and physical limitations, any weight-bearing activity is better than none. See our guide: Can I Exercise with Cirrhosis?

Fall prevention

In a patient with osteoporosis and impaired clotting, a fall that results in a fracture can be life-threatening. Practical fall prevention strategies include removing tripping hazards at home (loose rugs, cluttered pathways), installing grab bars in bathrooms, ensuring good lighting in hallways and stairs, wearing non-slip footwear, being cautious with medications that cause dizziness (especially diuretics and any sedating drugs), and — critically — monitoring for hepatic encephalopathy, which impairs coordination and increases fall risk.

Bisphosphonates (when indicated)

For patients with confirmed osteoporosis (T-score below -2.5) or history of fragility fracture, bisphosphonate therapy (alendronate, risedronate) may be considered. However, bisphosphonates carry a risk of esophageal irritation and ulceration — which is concerning in patients with esophageal varices. IV bisphosphonates (zoledronic acid) avoid this risk and may be preferred in some cirrhosis patients. The decision requires careful discussion between your hepatologist and endocrinologist.

Address hypogonadism

If testosterone is documented as low in men with cirrhosis, testosterone replacement therapy may be considered — both for bone health and for muscle preservation. However, testosterone therapy in liver disease is complex (it can worsen fluid retention and has theoretical concerns about liver tumors), so it must be managed by a specialist with liver expertise. In women, hormone replacement therapy decisions involve balancing bone benefit against cardiovascular and cancer risks — an individualized conversation with your healthcare team.

Pre-transplant bone optimization

If you're being evaluated for liver transplant, bone health optimization before surgery is critical. Bone loss accelerates dramatically in the first 3–6 months post-transplant due to high-dose corticosteroids and calcineurin inhibitors (tacrolimus, cyclosporine). Patients who enter transplant with pre-existing osteoporosis are at very high fracture risk during recovery. Getting a DEXA scan, repleting vitamin D, ensuring adequate calcium, and exercising before transplant are all investments in your post-transplant safety.

The post-transplant bone window

This deserves special mention because it surprises many patients: bone loss actually gets worse in the first 3–6 months after liver transplant before it gets better. The immunosuppressive medications needed to prevent organ rejection — particularly corticosteroids and calcineurin inhibitors — are potent drivers of bone resorption.

Bone density typically reaches its lowest point 3–6 months post-transplant. After that, as steroid doses are reduced and liver function normalizes (restoring vitamin D activation, hormone balance, and nutrition), bone density gradually improves. Most patients see significant bone recovery by 1–2 years post-transplant — but some never fully recover to pre-disease levels.

This is why pre-transplant bone optimization matters so much. If you enter transplant with a T-score of -2.8, the post-transplant nadir could push you into severely osteoporotic territory where vertebral and hip fractures become a real threat during your recovery — precisely when you need to be rehabilitating, not immobilized with a fracture.

Frequently asked questions

How common is bone disease in liver disease?

Osteoporosis is found in 12–55% of cirrhosis patients, depending on the study and the cause of liver disease. Cholestatic conditions (PBC, PSC) have the highest rates. Osteopenia (the precursor to osteoporosis) is even more common, affecting the majority of cirrhosis patients to some degree. When you include all forms of hepatic osteodystrophy, up to 40% of cirrhosis patients have clinically significant bone disease.

Should I get a DEXA scan?

If you have cirrhosis — particularly cholestatic disease, alcohol-related disease, are postmenopausal, are on long-term steroids, or are being evaluated for transplant — yes. A baseline DEXA scan is simple, painless, and provides actionable information. Ask your hepatologist if it's been ordered. If not, request it. The test takes 15 minutes and could prevent a fracture that changes your life.

Is vitamin D supplementation enough to prevent bone loss?

Vitamin D is necessary but usually not sufficient by itself. It corrects the deficiency that impairs calcium absorption — which is essential — but it doesn't address all the other mechanisms driving bone loss (inflammation, hypogonadism, direct alcohol toxicity, medication effects). A comprehensive approach includes vitamin D, calcium, exercise, fall prevention, and — for patients with confirmed osteoporosis — possibly bisphosphonate or hormone therapy. Think of vitamin D as the foundation, not the entire building.

Can bone loss from liver disease be reversed?

Partially. Vitamin D repletion and calcium supplementation can stabilize or modestly improve bone density. Exercise helps maintain what you have. Bisphosphonates can reduce fracture risk even without dramatic density improvement. And after successful liver transplant, bone density typically improves significantly as liver function normalizes — though this takes 1–2 years. Complete reversal to pre-disease bone density is uncommon, but meaningful improvement is achievable in most patients with treatment.

Does fatty liver cause bone loss?

Recent research suggests that NAFLD may be independently associated with reduced bone density — possibly through shared mechanisms of insulin resistance, chronic inflammation, and vitamin D deficiency. The association is less well-established than in cirrhosis, but patients with NAFLD and additional risk factors (diabetes, sedentary lifestyle, vitamin D deficiency) should be aware of their bone health. Exercise, vitamin D, calcium, and weight management protect both your liver and your bones.

I'm a man with cirrhosis — should I get my testosterone checked?

Yes. Hypogonadism (low testosterone) affects 50–90% of men with cirrhosis and contributes to bone loss, muscle wasting, fatigue, sexual dysfunction, and depression. It's one of the most impactful and most undertested hormonal disruptions in male cirrhosis patients. A simple morning blood test (total and free testosterone) can identify it. If deficient, treatment options exist — though they require careful management in the context of liver disease.

Your bones are silently losing density while your attention is on your liver. Get screened. Take vitamin D. Move your body. Don't let a preventable fracture derail a life you're working hard to protect.

→ Start Tracking Free

→ Calculate Your MELD Score

→ Download the iOS App

Medical Disclaimer: This article is for informational and educational purposes only. Bone health management should be individualized by your healthcare team. Never start bisphosphonates without medical evaluation, especially if you have esophageal varices. Visit livertracker.com/medical-disclaimer.